These emerging medications , Tirzepatide , represent a significant advancement in addressing type 2 diabetes and possibly related conditions . They are classified as GLP-1 pathway agonists , signifying they to mimic the body's GLP-1 peptide, stimulating glucose release and lowering hunger . Although Retatrutide each operates somewhat similarly, … Read More